Search

  3. ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board

    Press release

    LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced the appointment of Dr.

  6. Leadership

    Page

    … track record. Find out who is on our management team, board of directors and scientific advisory board. Management Team Management Team Daniel A. de …

    A close up of Daniel de Boer

  7. Analyst & Investor Axiomer® technology R&D Event

    Presentation

    This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the initial pipeline targets, and provided guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the extension of its cash runway guidance.

    Thumbnail of the R&D event 2023 presentation

  8. ProQR Therapeutics Virtual R&D Event 2023

    Webcast

    … A. de Boer, Founder and CEO, Gerard Platenburg, Chief Scientific Officer, and René Beukema, Chief Corporate … the University of California at Davis and ProQR Scientific Advisory Board member will also present. In addition, the Company …

  9. Analyst and Investor Event

    Webcast

    ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.